Canadian psychedelics firm MindBio Therapeutics Corp. (CSE: MBIO) on Friday released durability results from its Phase 2A trial for its patented take-home microdose version of lysergic acid diethylamide (LSD), designed to treat depression with “sub-hallucinogenic” doses. The trial found the drug “is a safe and effective drug for treating depression …
The Ohio Division of Cannabis Control has received 235 applications thus far from businesses hoping to either land recreational marijuana retail permits or add that feature to their existing medical cannabis shops. Some of the applications have already been approved, ABC 6 reported, which included medical marijuana growers, processors, and …
“Governors and lawmakers around the country are taking steps to right the past wrongs of cannabis criminalization. It’s a shame to see Louisiana’s Governor taking the state in a different direction.” The post Louisiana: Governor Vetoes Bill Facilitating Expedited Pardons for First-Time Marijuana Offenders appeared first on NORML.
An independent analysis by FTI Consulting on the potential of the Pennsylvania recreational marijuana market found that the state could hit up to $2.8 billion in sales in the first year of operations and create nearly 45,000 jobs. The study, paid for by nonprofit coalition Responsible PA, is part of …